What development phase is Lathyrol-3,15-Diacetate 5-Benzoate in?

Lathyrol-3,15-Diacetate 5-Benzoate is FDA-approved (marketed).

What is the generic name of Lathyrol-3,15-Diacetate 5-Benzoate?

diacetyl benzoyl lathyrol is the generic (nonproprietary) name of Lathyrol-3,15-Diacetate 5-Benzoate.

Last reviewed 2026-04-20 · How we verify

Lathyrol-3,15-Diacetate 5-Benzoate (diacetyl benzoyl lathyrol)

FDA-approved active Quality 6/100

At a glance

Generic name	diacetyl benzoyl lathyrol
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Lathyrol-3,15-Diacetate 5-Benzoate CI brief — competitive landscape report
Lathyrol-3,15-Diacetate 5-Benzoate updates RSS · CI watch RSS
portfolio CI